RTW INVESTMENTS, LP Q3 2020 Filing
Filed November 16, 2020
Portfolio Value
$4.2T
Holdings
90
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (90 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | RCKTRocket Pharmaceuticals Inc | 16,812,491 | $384.3B | 9.25% | |
| 2 | IMVTImmunovant Inc | 7,510,412 | $264.3B | 6.36% | |
| 3 | ALNYAlnylam Pharmaceuticals Inc | 1,681,645 | $244.8B | 5.90% | |
| 4 | PTCTPTC Therapeutics Inc | 3,993,286 | $186.7B | 4.49% | |
| 5 | MRTXEURMirati Therapeutics Inc | 1,096,005 | $182.0B | 4.38% | |
| 6 | —Dicerna Pharmaceuticals Inc | 7,227,413 | $130.0B | 3.13% | |
| 7 | —Myokardia Inc | 936,931 | $127.7B | 3.08% | |
| 8 | NTRANatera Inc | 1,710,769 | $123.6B | 2.98% | |
| 9 | AXSMAxsome Therapeutics Inc | 1,670,938 | $119.1B | 2.87% | |
| 10 | STOKStoke Therapeutics Inc | 3,544,248 | $118.7B | 2.86% | |
| 11 | RNAAvidity Biosciences Inc | 3,995,000 | $109.9B | 2.65% | |
| 12 | 3M4Masimo Corp | 450,390 | $106.3B | 2.56% | |
| 13 | CERNCHFCerner Corp | 1,392,049 | $100.6B | 2.42% | |
| 14 | AXNX*Axonics Modulation Technologies Inc | 1,883,864 | $96.2B | 2.32% | |
| 15 | BAXBaxter International Inc | 1,077,268 | $86.6B | 2.09% | |
| 16 | TXG10x Genomics Inc | 660,933 | $82.4B | 1.98% | |
| 17 | ADVMCHFAdverum Biotechnologies Inc | 7,234,764 | $74.5B | 1.79% | |
| 18 | VCELVericel Corp | 3,850,851 | $71.4B | 1.72% | |
| 19 | TNDMTandem Diabetes Care Inc | 603,481 | $68.5B | 1.65% | |
| 20 | PTGXProtagonist Therapeutics Inc | 3,408,961 | $66.6B | 1.60% | |
| 21 | RLMDRelmada Therapeutics Inc | 1,511,337 | $56.9B | 1.37% | |
| 22 | ILMNIllumina Inc | 175,000 | $54.1B | 1.30% | |
| 23 | GHGuardant Health Inc | 469,498 | $52.5B | 1.26% | |
| 24 | AGENEURAgenus Inc | 12,864,677 | $51.5B | 1.24% | |
| 25 | —Translate Bio Inc | 3,745,286 | $51.0B | 1.23% | |
| 26 | —Frequency Therapeutics Inc | 2,461,486 | $47.3B | 1.14% | |
| 27 | TCE2Celldex Therapeutics Inc | 3,120,137 | $46.3B | 1.11% | |
| 28 | —Athira Pharma Inc | 2,668,913 | $45.4B | 1.09% | |
| 29 | ESTAEstablishment Labs Holdings Inc | 2,319,138 | $43.0B | 1.03% | |
| 30 | NSTGEURNanoString Technologies Inc | 947,134 | $42.3B | 1.02% | |
| 31 | CYTKCytokinetics Inc Private | 2,000,000 | $40.7B | 0.98% | |
| 32 | OYSTOyster Point Pharma Inc | 1,923,893 | $40.6B | 0.98% | |
| 33 | CSTLCastle Biosciences Inc | 743,642 | $38.3B | 0.92% | |
| 34 | OPHTEURIVERIC bio Inc | 6,663,439 | $37.6B | 0.90% | |
| 35 | DMTKQDermTech Inc | 2,887,215 | $34.5B | 0.83% | |
| 36 | MGNXMacroGenics Inc | 1,255,299 | $31.6B | 0.76% | |
| 37 | MISTMilestone Pharmaceuticals Inc | 4,315,102 | $31.6B | 0.76% | |
| 38 | TREURTrillium Therapeutics Inc | 2,160,800 | $30.7B | 0.74% | |
| 39 | INCYIncyte Corp | 334,144 | $30.0B | 0.72% | |
| 40 | AVDLAvadel Pharmaceuticals plc | 5,366,705 | $27.0B | 0.65% | |
| 41 | FIXXEURHomology Medicines Inc | 2,517,906 | $26.9B | 0.65% | |
| 42 | EP3OraSure Technologies Inc | 2,075,082 | $25.3B | 0.61% | |
| 43 | PRQRProQR Therapeutics NV | 4,973,174 | $23.8B | 0.57% | |
| 44 | VXRTVaxart Inc | 3,517,345 | $23.4B | 0.56% | |
| 45 | BLIUSDBerkeley Lights Inc | 300,338 | $22.9B | 0.55% | |
| 46 | TELATela Bio Inc | 1,378,776 | $22.8B | 0.55% | |
| 47 | JNJJohnson & Johnson | 149,761 | $22.3B | 0.54% | |
| 48 | 5E7Iteos Therapeutics Inc | 902,855 | $20.9B | 0.50% | |
| 49 | ADAPYAdaptimmune Therapeutics PLC | 2,617,626 | $20.9B | 0.50% | |
| 50 | OMGBPOutset Medical Inc | 405,000 | $20.3B | 0.49% | |
| 51 | I9DNArbutus Biopharma Corp | 5,978,355 | $18.7B | 0.45% | |
| 52 | PMVPPmv Pharmaceuticals Inc | 500,000 | $17.8B | 0.43% | |
| 53 | ALTAltimmune Inc | 1,334,940 | $17.6B | 0.42% | |
| 54 | MDXGMiMedx Group Inc | 2,700,320 | $17.2B | 0.41% | |
| 55 | IMUXImmunic Inc | 912,496 | $16.9B | 0.41% | |
| 56 | APYXApyx Medical Corp | 3,391,279 | $16.0B | 0.38% | |
| 57 | AMRSEURAmyris Inc | 5,161,347 | $15.1B | 0.36% | |
| 58 | XGNExagen Inc | 1,250,131 | $13.6B | 0.33% | |
| 59 | AFIBAcutus Medical Inc | 451,834 | $13.5B | 0.32% | |
| 60 | —Odonate Therapeutics Inc | 999,256 | $13.4B | 0.32% | |
| 61 | —GenMark Diagnostics Inc | 762,994 | $10.8B | 0.26% | |
| 62 | ARCTArcturus Therapeutics Ltd | 251,236 | $10.8B | 0.26% | |
| 63 | CTMXCytomx Therapeutics Inc | 1,526,003 | $10.1B | 0.24% | |
| 64 | —La Jolla Pharmaceutical Co | 2,395,029 | $9.7B | 0.23% | |
| 65 | BLUBellus Health Inc | 4,195,356 | $9.5B | 0.23% | |
| 66 | —Itamar Medical Ltd | 457,218 | $9.3B | 0.22% | |
| 67 | FULCFulcrum Therapeutics Inc | 1,150,565 | $9.1B | 0.22% | |
| 68 | INMDInmode Ltd | 250,000 | $9.0B | 0.22% | |
| 69 | RGNXRegenxbio Inc | 318,434 | $8.8B | 0.21% | |
| 70 | ARGXargenx SE | 31,752 | $8.3B | 0.20% | |
| 71 | —Therapeutics Acquisition Corp | 490,000 | $7.0B | 0.17% | |
| 72 | TMDXTransmedics Group Inc | 503,266 | $6.9B | 0.17% | |
| 73 | —Lifesci Acquisition Corp | 500,000 | $6.8B | 0.16% | |
| 74 | BWAYBrainsway Ltd | 1,107,420 | $6.5B | 0.16% | |
| 75 | —BCTG Acquisition Corp | 600,000 | $6.2B | 0.15% | |
| 76 | CLSDUSDClearside Biomedical Inc | 3,947,518 | $6.1B | 0.15% | |
| 77 | QUREUniqure NV | 158,479 | $5.8B | 0.14% | |
| 78 | EQEquillium Inc | 1,004,784 | $5.8B | 0.14% | |
| 79 | PSNLPersonalis Inc | 255,000 | $5.5B | 0.13% | |
| 80 | —Arya Sciences Acquisition II Corp | 500,000 | $5.5B | 0.13% | |
| 81 | —Arya Sciences Acquisition Corp | 500,000 | $5.4B | 0.13% | |
| 82 | PRNProfound Medical Corp | 244,193 | $4.3B | 0.10% | |
| 83 | PHGEBiomx Inc | 600,000 | $3.8B | 0.09% | |
| 84 | IMTXImmatics Nv | 350,000 | $3.7B | 0.09% | |
| 85 | —Panacea Acquisition Corp | 300,000 | $3.6B | 0.09% | |
| 86 | —Chardan Healthcare Acquisition 2 Corp | 350,000 | $3.6B | 0.09% | |
| 87 | —Progenity Inc | 275,000 | $2.5B | 0.06% | |
| 88 | TWSTTwist Bioscience Corp | 18,473 | $1.4B | 0.03% | |
| 89 | BNRBurning Rock Biotech Ltd | 30,000 | $752.0M | 0.02% | |
| 90 | PHGEBiomX Equities Warrant Exp 13 Dec 2023 | 600,000 | $426.0M | 0.01% |